IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Catalyst Pharmaceuticals Inc (CPRX)

CUSIP: 14888U101 | NYSE | Healthcare · Biotechnology | Mid Cap | 956 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

IFP Advisors, Inc1,533
0.0% of portfolio›$48.2K
StyleTurnoverLocationFiled
IFP Advisors, Inc
1,533$48.2K0.0%GrowthLowTampa, FL2026-10-16